{"id":"https://openalex.org/W2145846489","doi":"https://doi.org/10.5402/2012/965280","title":"Effect of Chemical Enhancers in Transdermal Permeation of Alfuzosin Hydrochloride","display_name":"Effect of Chemical Enhancers in Transdermal Permeation of Alfuzosin Hydrochloride","publication_year":2012,"publication_date":"2012-12-20","ids":{"openalex":"https://openalex.org/W2145846489","doi":"https://doi.org/10.5402/2012/965280","mag":"2145846489","pmid":"https://pubmed.ncbi.nlm.nih.gov/23316394","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3539352"},"language":"en","primary_location":{"id":"doi:10.5402/2012/965280","doi":"https://doi.org/10.5402/2012/965280","is_oa":true,"landing_page_url":"https://doi.org/10.5402/2012/965280","pdf_url":"https://downloads.hindawi.com/archive/2012/965280.pdf","source":{"id":"https://openalex.org/S4210178753","display_name":"ISRN Pharmaceutics","issn_l":"2090-6145","issn":["2090-6145","2090-6153"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISRN Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://downloads.hindawi.com/archive/2012/965280.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103325513","display_name":"D Prasanthi","orcid":"https://orcid.org/0000-0002-3856-814X","observed_orcids":["https://orcid.org/0000-0002-3856-814X"]},"institutions":[{"id":"https://openalex.org/I4405263311","display_name":"G. Pulla Reddy College of Pharmacy","ror":"https://ror.org/053xha254","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405263311"]},{"id":"https://openalex.org/I8975392","display_name":"Osmania University","ror":"https://ror.org/030sjb889","country_code":"IN","type":"education","lineage":["https://openalex.org/I8975392"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"D. Prasanthi","raw_affiliation_strings":["Department of Pharmaceutics, G. Pulla Reddy College of Pharmacy, Osmania University, Hyderabad, Andhra Pradesh 500 028, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, G. Pulla Reddy College of Pharmacy, Osmania University, Hyderabad, Andhra Pradesh 500 028, India","institution_ids":["https://openalex.org/I4405263311","https://openalex.org/I8975392"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112971911","display_name":"P K Lakshmi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405263311","display_name":"G. Pulla Reddy College of Pharmacy","ror":"https://ror.org/053xha254","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405263311"]},{"id":"https://openalex.org/I8975392","display_name":"Osmania University","ror":"https://ror.org/030sjb889","country_code":"IN","type":"education","lineage":["https://openalex.org/I8975392"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"P. K. Lakshmi","raw_affiliation_strings":["Department of Pharmaceutics, G. Pulla Reddy College of Pharmacy, Osmania University, Hyderabad, Andhra Pradesh 500 028, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, G. Pulla Reddy College of Pharmacy, Osmania University, Hyderabad, Andhra Pradesh 500 028, India","institution_ids":["https://openalex.org/I4405263311","https://openalex.org/I8975392"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5112971911"],"corresponding_institution_ids":["https://openalex.org/I4405263311","https://openalex.org/I8975392"],"apc_list":null,"apc_paid":null,"fwci":1.0944,"has_fulltext":true,"cited_by_count":33,"citation_normalized_percentile":{"value":0.70757004,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":98},"biblio":{"volume":"2012","issue":null,"first_page":"1","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alfuzosin-hydrochloride","display_name":"alfuzosin hydrochloride","score":0.9850000143051147},{"id":"https://openalex.org/keywords/transdermal-drug-delivery","display_name":"transdermal drug delivery","score":0.8799999952316284},{"id":"https://openalex.org/keywords/chemical-penetration-enhancers","display_name":"chemical penetration enhancers","score":0.949999988079071},{"id":"https://openalex.org/keywords/tween-20","display_name":"Tween 20","score":0.8889999985694885},{"id":"https://openalex.org/keywords/oleic-acid","display_name":"oleic acid","score":0.9760000109672546},{"id":"https://openalex.org/keywords/carbopol-gel","display_name":"Carbopol gel","score":0.8700000047683716},{"id":"https://openalex.org/keywords/stratum-corneum-barrier","display_name":"stratum corneum barrier","score":0.9570000171661377},{"id":"https://openalex.org/keywords/skin-permeation","display_name":"skin permeation","score":0.8240000009536743},{"id":"https://openalex.org/keywords/skin-irritation","display_name":"skin irritation","score":0.5609999895095825},{"id":"https://openalex.org/keywords/alpha-1-adrenergic-blockers","display_name":"alpha-1 adrenergic blockers","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.8914408683776855},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7284244894981384},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5854601860046387},{"id":"https://openalex.org/C50670333","wikidata":"https://www.wikidata.org/wiki/Q907651","display_name":"Permeation","level":3,"score":0.5798707008361816},{"id":"https://openalex.org/C80107235","wikidata":"https://www.wikidata.org/wiki/Q7162625","display_name":"Penetration (warfare)","level":2,"score":0.5422452688217163},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5299414396286011},{"id":"https://openalex.org/C2781403372","wikidata":"https://www.wikidata.org/wiki/Q207688","display_name":"Oleic acid","level":2,"score":0.4886839687824249},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14120563864707947},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.12536269426345825},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.12260153889656067},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C42475967","wikidata":"https://www.wikidata.org/wiki/Q194292","display_name":"Operations research","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.5402/2012/965280","doi":"https://doi.org/10.5402/2012/965280","is_oa":true,"landing_page_url":"https://doi.org/10.5402/2012/965280","pdf_url":"https://downloads.hindawi.com/archive/2012/965280.pdf","source":{"id":"https://openalex.org/S4210178753","display_name":"ISRN Pharmaceutics","issn_l":"2090-6145","issn":["2090-6145","2090-6153"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISRN Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:23316394","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23316394","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISRN pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3539352","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3539352/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISRN Pharm","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.816.437","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.816.437","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/08/41/ISRN.PHARMACEUTICS2012-965280.PMC3539352.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.5402/2012/965280","doi":"https://doi.org/10.5402/2012/965280","is_oa":true,"landing_page_url":"https://doi.org/10.5402/2012/965280","pdf_url":"https://downloads.hindawi.com/archive/2012/965280.pdf","source":{"id":"https://openalex.org/S4210178753","display_name":"ISRN Pharmaceutics","issn_l":"2090-6145","issn":["2090-6145","2090-6153"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISRN Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2145846489.pdf","grobid_xml":"https://content.openalex.org/works/W2145846489.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1550353272","https://openalex.org/W1978537309","https://openalex.org/W1982328592","https://openalex.org/W1986444327","https://openalex.org/W1991691495","https://openalex.org/W1993076102","https://openalex.org/W1993144465","https://openalex.org/W2006011639","https://openalex.org/W2029218076","https://openalex.org/W2033198837","https://openalex.org/W2041887917","https://openalex.org/W2045113751","https://openalex.org/W2046667253","https://openalex.org/W2050426841","https://openalex.org/W2050607403","https://openalex.org/W2085094352","https://openalex.org/W2089313881","https://openalex.org/W2102250394","https://openalex.org/W4240821889"],"related_works":["https://openalex.org/W7097099723","https://openalex.org/W2099593891","https://openalex.org/W2070776842","https://openalex.org/W1998697288","https://openalex.org/W2366604673","https://openalex.org/W2996652204","https://openalex.org/W7056374881","https://openalex.org/W2055531665","https://openalex.org/W2323161542","https://openalex.org/W2758403093"],"abstract_inverted_index":{"The":[0,32,156],"objective":[1],"of":[2,28,95,113,127,151,160,173,192,203,211,227],"the":[3,9,15,21,60,69,72,76,88,96,99,108,209,214,217],"present":[4],"study":[5],"is":[6,221],"to":[7],"explore":[8],"efficient":[10,222],"chemical":[11],"penetration":[12],"enhancer":[13],"among":[14],"various":[16,100],"enhancers":[17,34,70,101,219],"available":[18],"in":[19,25,37,50,206,223],"overcoming":[20],"stratum":[22],"corneum":[23],"barrier":[24],"transdermal":[26,225],"delivery":[27,226],"Alfuzosin":[29],"hydrochloride":[30],"(AH).":[31],"different":[33,218],"were":[35,186],"incorporated":[36],"2%":[38],"Carbopol":[39],"gel":[40],"which":[41,86],"was":[42,143,165,177],"selected":[43],"as":[44,199],"a":[45],"control":[46,82],"and":[47,57,104,118,135,201],"evaluated":[48],"by":[49,132,140,175],"vitro":[51],"diffusion":[52,66],"studies":[53,185,191],"through":[54,59,75],"dialysis":[55,77],"membrane":[56,78],"permeation":[58],"rat":[61],"abdominal":[62],"skin":[63,158,183],"using":[64],"Keshary-Chien":[65],"cells.":[67],"All":[68],"increased":[71],"release":[73,89],"rate":[74,90,126],"when":[79],"compared":[80],"with":[81,167,179,188],"except":[83],"oleic":[84,168],"acid":[85,169],"decreased":[87,148],"but":[91],"showed":[92,107,147,195],"maximum":[93],"solubility":[94],"drug.":[97],"Among":[98,216],"Transcutol":[102,133,145],"20%":[103,134,146,194],"tween-20":[105,141],"(2%)":[106,142],"highest":[109],"cumulative":[110],"amount":[111],"(Q(24))":[112],"702.28":[114],"\u00b1":[115,120,129,137,153,162],"6.97":[116],"\u03bcg/cm(2)":[117],"702.74":[119],"7.49":[121],"\u03bcg/cm(2),":[122],"respectively.":[123],"A":[124],"flux":[125,174],"31.08":[128],"0.21":[130],"\u03bcg/cm(2)/hr":[131,139],"30.38":[136],"0.18":[138],"obtained.":[144],"lag":[149],"time":[150],"0.13":[152],"0.05":[154],"hr.":[155],"lowest":[157],"content":[159],"342.33":[161],"5.30":[163],"\u03bcg/gm":[164],"seen":[166],"2.5%.":[170],"Maximum":[171],"enhancement":[172],"3.94-fold":[176],"obtained":[178],"transcutol":[180,193,212,220],"20%.":[181],"Primary":[182],"irritation":[184],"performed":[187],"rabbit.":[189],"Histopathological":[190],"marked":[196],"changes":[197],"such":[198],"degeneration":[200],"infiltration":[202],"mononuclear":[204],"cells":[205],"dermis":[207],"indicating":[208],"effect":[210],"on":[213],"skin.":[215],"enhancing":[224],"AH.":[228]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}